4basebio signs strategic collaboration, marketing agreement with Genezen on synthetic DNA for viral vectors
Valerio Therapeutics signs deal to buy Etherna Immunotherapies for €30 million enterprise value
Charles River and MVC to develop enterovirus vaccine
AI isn’t close to curing cancer. This startup says it knows what it will take.
Oncoinvent publishes investor presentation on Radspherin alpha therapy for peritoneal metastases
Quantum - Si - CW27 | 10-Q: FY2026 Q1 Revenue: USD 258 K